| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5207563
Max Phase: Preclinical
Molecular Formula: C16H12ClNO4
Molecular Weight: 317.73
Associated Items:
Representations
Canonical SMILES: Oc1ccc(Oc2ccccc2Cl)c(Cc2cc(O)no2)c1
Standard InChI: InChI=1S/C16H12ClNO4/c17-13-3-1-2-4-15(13)21-14-6-5-11(19)7-10(14)8-12-9-16(20)18-22-12/h1-7,9,19H,8H2,(H,18,20)
Standard InChI Key: YENZLOICJNDRKG-UHFFFAOYSA-N
Associated Targets(non-human)
CaM kinase II alpha 109 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 317.73 | Molecular Weight (Monoisotopic): 317.0455 | AlogP: 4.12 | #Rotatable Bonds: 4 |
| Polar Surface Area: 75.72 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 5.21 | CX Basic pKa: | CX LogP: 4.29 | CX LogD: 2.42 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.76 | Np Likeness Score: -0.41 |
References
| 1. Tian Y, Shehata MA, Gauger SJ, Ng CKL, Solbak S, Thiesen L, Bruus-Jensen J, Krall J, Bundgaard C, Gibson KM, Wellendorph P, Frølund B.. (2022) Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain., 65 (9.0): [PMID:35500061] [10.1021/acs.jmedchem.1c02177] |
Source
Source(1):